Mi-Kyung Jeong

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 17

Top Topics

Combination Therapy

Dna Methylation

Small Cell Lung Cancer

Top Venues

Integrative cancer therapies

International journal of environmental research and public health

Journal of clinical medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Jung-Hyang Park, Eunbin Kwag, Mi-Kyung Jeong, So-Jung Park, Sanghun Lee, Hwa Seung Yoo
Genome-wide Analysis Identified SEMA4D , Novel Candidate Gene for Temperature Sensitivity in Patients With Non-Small Cell Lung Cancer. Integrative cancer therapies 23 (2024)
Eunbin Kwag, Soo-Dam Kim, Seong Hoon Shin, Chulho Oak, So-Jung Park, Jun-Yong Choi, Seong Hoon Yoon, In-Cheol Kang, Mi-Kyung Jeong, Hyun Woo Lee, Sun-Hwi Bang, Ji Woong Son, Sanghun Lee, Seung Joon Kim, Hwa Seung Yoo
A Randomized, Multi-Center, Open Label Study to Compare the Safety and Efficacy between Afatinib Monotherapy and Combination Therapy with HAD-B1 for the Locally Advanced or Metastatic NSCLC Patients with EGFR Mutations. Integrative cancer therapies 23 (2024)
Eunbin Kwag, Soo-Dam Kim, Seong Hoon Shin, Chulho Oak, So-Jung Park, Jun-Yong Choi, Seong Hoon Yoon, In-Cheol Kang, Mi-Kyung Jeong, Hyun Woo Lee, Sun-Hwi Bang, Ji Woong Son, Sanghun Lee, Seung Joon Kim, Hwa Seung Yoo
A Randomized, Multi-Center, Open Label Study to Compare the Safety and Efficacy between Afatinib Monotherapy and Combination Therapy with HAD-B1 for the Locally Advanced or Metastatic NSCLC Patients with EGFR Mutations. Integrative cancer therapies 23 (2024)
Jung-Hyang Park, Eunbin Kwag, Mi-Kyung Jeong, So-Jung Park, Sanghun Lee, Hwa Seung Yoo
Genome-wide Analysis Identified SEMA4D , Novel Candidate Gene for Temperature Sensitivity in Patients With Non-Small Cell Lung Cancer. Integrative cancer therapies 23 (2024)
Jung-Hyang Park, Eunbin Kwag, Mi-Kyung Jeong, So-Jung Park, Sanghun Lee, Hwa Seung Yoo
Genome-wide Analysis Identified SEMA4D , Novel Candidate Gene for Temperature Sensitivity in Patients With Non-Small Cell Lung Cancer. Integrative cancer therapies 23 (2024)
Jung-Hyang Park, Eunbin Kwag, Mi-Kyung Jeong, So-Jung Park, Sanghun Lee, Hwa Seung Yoo
Genome-wide Analysis Identified SEMA4D , Novel Candidate Gene for Temperature Sensitivity in Patients With Non-Small Cell Lung Cancer. Integrative cancer therapies 23 (2024)
Eunbin Kwag, Soo-Dam Kim, Seong Hoon Shin, Chulho Oak, So-Jung Park, Jun-Yong Choi, Seong Hoon Yoon, In-Cheol Kang, Mi-Kyung Jeong, Hyun Woo Lee, Sun-Hwi Bang, Ji Woong Son, Sanghun Lee, Seung Joon Kim, Hwa Seung Yoo
A Randomized, Multi-Center, Open Label Study to Compare the Safety and Efficacy between Afatinib Monotherapy and Combination Therapy with HAD-B1 for the Locally Advanced or Metastatic NSCLC Patients with EGFR Mutations. Integrative cancer therapies 23 (2024)
Jung-Hyang Park, Eunbin Kwag, Mi-Kyung Jeong, So-Jung Park, Sanghun Lee, Hwa Seung Yoo
Genome-wide Analysis Identified SEMA4D , Novel Candidate Gene for Temperature Sensitivity in Patients With Non-Small Cell Lung Cancer. Integrative cancer therapies 23 (2024)
Mi Mi Ko, Mi-Kyung Jeong, Chang-Min Choi, Seung-Hyeun Lee, Jaemoo Chun, Jin-Mu Yi, Ho Jang, Sung Yong Lee
Safety and Efficacy of Bojungikki-Tang in Advanced NSCLC Patients Receiving Treatment with Immune Checkpoint Inhibitors: Protocol for a Multicenter, Double-Blind, Randomized, Placebo-Controlled Pilot Trial. International journal of environmental research and public health 20 (5) (2023)
Mi Mi Ko, Mi-Kyung Jeong, Chang-Min Choi, Seung-Hyeun Lee, Jaemoo Chun, Jin-Mu Yi, Ho Jang, Sung Yong Lee
Safety and Efficacy of Bojungikki-Tang in Advanced NSCLC Patients Receiving Treatment with Immune Checkpoint Inhibitors: Protocol for a Multicenter, Double-Blind, Randomized, Placebo-Controlled Pilot Trial. International journal of environmental research and public health 20 (5) (2023)
Jaemoo Chun, Sang-Min Park, Minsung Lee, In Jin Ha, Mi-Kyung Jeong
The Sesquiterpene Lactone-Rich Fraction of Inula helenium L. Enhances the Antitumor Effect of Anti-PD-1 Antibody in Colorectal Cancer: Integrative Phytochemical, Transcriptomic, and Experimental Analyses. Cancers 15 (3) (2023)
Jaemoo Chun, Sang-Min Park, Minsung Lee, In Jin Ha, Mi-Kyung Jeong
The Sesquiterpene Lactone-Rich Fraction of Inula helenium L. Enhances the Antitumor Effect of Anti-PD-1 Antibody in Colorectal Cancer: Integrative Phytochemical, Transcriptomic, and Experimental Analyses. Cancers 15 (3) (2023)
Mi Mi Ko, Mi-Kyung Jeong, Chang-Min Choi, Seung-Hyeun Lee, Jaemoo Chun, Jin-Mu Yi, Ho Jang, Sung Yong Lee
Safety and Efficacy of Bojungikki-Tang in Advanced NSCLC Patients Receiving Treatment with Immune Checkpoint Inhibitors: Protocol for a Multicenter, Double-Blind, Randomized, Placebo-Controlled Pilot Trial. International journal of environmental research and public health 20 (5) (2023)
Mi-Kyung Jeong, Jaemoo Chun, In Jae Oh
Novel Biomarkers in Lung Cancer and Chronic Lung Diseases: From the Systematic Perspective of Yin-Yang Balance. Journal of clinical medicine 11 (15) (2022)
Ho Jang, Chang-Min Choi, Seung-Hyeun Lee, Sungyong Lee, Mi-Kyung Jeong
Read Count Patterns and Detection of Cancerous Copy Number Alterations in Plasma Cell-Free DNA Whole Exome Sequencing Data for Advanced Non-Small Cell Lung Cancer. International journal of molecular sciences 23 (21) (2022)
Eun-Bin Kwag, Soo-Dam Kim, Ji Hye Park, So-Jung Park, Mi-Kyung Jeong, Hwa-Seung Yoo
The Current Status of Integrative Oncology in Korea. Integrative cancer therapies 20 (2022)
Yujin Choi, O-Jin Kwon, Chang-Min Choi, Mi-Kyung Jeong
A Pilot Study of Whether the Cold-Heat Syndrome Type is Associated with Treatment Response and Immune Status in Patients with Non-Small Cell Lung Cancer. Evidence-based complementary and alternative medicine : eCAM 2021 (2021)